What Is the State Registration of Medical Devices and What Is Its Purpose?

The state registration of medical equipment and medical devices is the statutory pre-market assessment procedure governing the regulatory verification of safety, quality, and clinical efficacy of healthcare products across the Eurasian Economic Union. It protects patients and healthcare professionals from substandard, ineffective, or hazardous products.

The evaluation is not administered by private testing bodies, but falls directly under the jurisdiction of the competent state health authorities of the member states (in the Russian Federation by Roszdravnadzor, in the Republic of Kazakhstan by the Committee for Medical and Pharmaceutical Control of the Ministry of Healthcare).

Following the successful completion of all documentation reviews, laboratory trials, and manufacturing audits, the regulatory bodies grant an official Registration Certificate (Russian: Регистрационное удостоверение – РУ). Without this certificate, the importation, customs clearance, commercial distribution, and clinical application of medical devices in the EAEU territory are strictly prohibited by law.

State registration of medical devices in the EAEU

The legal foundation of the common medical device market was instituted by the Agreement on Common Principles and Rules for the Circulation of Medical Devices within the Scope of the EAEU. The regulatory framework relies primarily on the following core decisions:

Legal Act Regulatory Scope and Status 2026
Decision No. 46 of 12.02.2016 Rules for the registration and evaluation of the safety, quality, and efficacy of medical devices within the EAEU (procedure governing reference and recognition states, as amended by Decision No. 50).
Protocol of 29.12.2025 Extension of Dual Registration Option until 31.12.2027: Manufacturers retain the legal right to apply either through national routes (e.g., Russia only) or via the unified supranational EAEU system until the end of 2027.
Decision No. 106 / No. 43/2026 Requirements for the Quality Management System (QMS based on ISO 13485). The revised version No. 43/2026 (effective since 18.06.2026) binds inspection deadlines and outsourced operations to strict criteria.
Decision No. 173 of 22.12.2015 Classification rules defining four risk classes (Classes 1, 2a, 2b, and 3) based on potential operational risk, duration of use, and invasiveness.
Decision No. 27 of 12.02.2016 General safety and performance requirements for medical devices, technical labeling standards, and operational documentation specifications.
Decision No. 26 of 12.02.2016 Statutory requirements regarding the special conformity mark for medical devices placed on the EAEU market (EAC-MED mark).

Definition and Distinction from Medicinal Products (Pharmaceuticals)

Medical devices are defined as any instruments, apparatus, appliances, equipment, materials, reagents, and standalone software intended by the manufacturer to be used, individually or in combination, for human healthcare purposes. Their primary intended action in or on the human body is not achieved by pharmacological, immunological, or metabolic means, although their function may be assisted by such agents.

The intended purpose encompasses, among others:

  • Diagnosis, prevention, monitoring, treatment, or alleviation of disease or injury
  • Investigation, replacement, or modification of the anatomical structure or a physiological process
  • Compensation for an impairment or disability
  • Control of conception
  • In-vitro diagnostic (IVD) reagents and equipment for examining specimens derived from the human body

Classification into Risk Classes

Under Decision No. 173, medical devices are categorized into four classes according to their potential risk profile. The designated classification directly determines the scope of evidence required, the experimental study designs, and the necessity of on-site manufacturing audits:

Class Risk Potential Typical Product Examples Testing and Inspection Requirements
Class 1 Low risk Medical protective clothing, mechanical hospital beds, non-invasive surgical instruments, laboratory microscopes, basic dressing materials Clinical data can frequently be supported via literature route; mandatory on-site QMS manufacturing audit is not required.
Class 2a Moderate risk Diagnostic ultrasound equipment, laboratory clinical chemistry analyzers, inhalers, dental filling materials, corrective contact lenses Comprehensive technical and toxicological testing; mandatory on-site QMS audit applies primarily to sterile product categories.
Class 2b Elevated risk Defibrillators, diagnostic X-ray systems, infusion pumps, intensive care ventilators, condoms, hemodialysis equipment Comprehensive clinical trials; statutory manufacturing site inspection (QMS audit) is mandatory prior to registration approval.
Class 3 High risk Cardiovascular pacemakers, artificial heart valves, vascular stents, bioresorbable surgical implants, major joint endoprostheses Mandatory clinical trials with direct patient involvement; subject to the most rigorous manufacturing inspection regime.

The Two-Phase Procedure of State Registration

The centralized registration workflow under EAEU rules (Decision No. 46) is structured into two successive phases:

Phase I: Technical Dossier Compilation, Trial Approvals, and Laboratory Testing

  1. Classification and Regulatory Strategy: Analyzing intended clinical purpose, verifying the exact classification rule, and selecting both the Reference State (handling the primary evaluation) and the chosen Recognition States.
  2. Drafting the Registration Dossier: Structuring the comprehensive technical documentation (Technical File), compiling risk management files (ISO 14971), preparing clinical evaluation reports, and executing certified Russian translations.
  3. Obtaining the Official Import Permit: Securing the statutory import permit from the health authority of the Reference State to legally import test samples solely for trial purposes.
  4. Sample Customs Clearance and Laboratory Trials: Importing representative product samples and executing laboratory trials in state-accredited testing centers (technical safety, biocompatibility/toxicology, and EMC).
  5. Clinical Evaluation / Clinical Trials: Executing local clinical trials or preparing a comprehensive clinical evaluation report complying with EAEU guidelines.
  6. Manufacturing Site Inspection (QMS Audit): For Classes 2a (sterile), 2b, and 3, designated inspectorates perform an on-site audit of the manufacturing facility to verify EAEU QMS conformity (Decisions No. 106 and No. 43/2026).

Phase II: Official Regulatory Assessment and Mutual Recognition

  1. Expert Review by the Reference Authority: Submitting the finalized submission dossier including all trial protocols. The authority conducts an exhaustive review and issues an official assessment report regarding safety, quality, and efficacy.
  2. Recognition Procedure in Participating Member States: Transmitting the positive expert evaluation report to the national health authorities of the selected Recognition States for mutual confirmation.
  3. Issuance of the Registration Certificate: Upon final clearance, the competent authorities register the medical device in the centralized EAEU registry and issue the permanent Registration Certificate.

Einfuhr von Prüfmustern: Die behördliche Einfuhrgenehmigung

Legally introducing medical device samples into the EAEU customs territory for technical, toxicological, or clinical trials requires an official import permit (issued in Russia by Roszdravnadzor).

Customs officials will strictly deny clearance for test samples lacking this authorization. The permit remains valid for a limited period (typically 6 months) and covers the exact physical unit count required for the approved testing program.

Required Documentation for the Import Permit:

  • Formal application listing exact model designations, serial numbers, batch identifiers, and intended testing scope
  • Preliminary service contract executed with the accredited testing laboratory performing the trials
  • Notarized and legalized Power of Attorney issued to the Authorized Representative
  • Technical product data sheet and draft of the Instructions for Use (IFU) in Russian
Laboratory testing and microscopy for medical devices

The Letter of Exemption (Negative Confirmation / Otkaznoye Pismo)

For borderline products, research-grade laboratory equipment, fitness devices, or industrial instruments that share physical resemblance with medical technology, customs authorities and hospital procurement bodies frequently demand official proof confirming exemption from mandatory medical registration.

A formal Letter of Exemption issued by the Ministry of Healthcare or Roszdravnadzor certifies that the designated product, evaluated against its declared intended purpose and customs tariff code (HS / TN VED), is not legally classified as a registrable medical device. It prevents costly customs hold-ups and acts as a verified commercial clearance document.

Required Application Inputs:

  • Technical data sheet and comprehensive functional description
  • Explicit declaration of intended use strictly excluding medical, diagnostic, or therapeutic claims
  • Customs tariff classification code (HS Code / TN VED)
  • Commercial supply contract, proforma invoice, and transport documentation

Regulatory Interfaces with Technical Regulations (EMC) and Metrology

Medical devices are subject to distinct interface requirements intersecting with broader EAEU technical standards:

1. Electromagnetic Compatibility (TR CU 020/2011):
Active medical devices capable of generating electromagnetic fields or vulnerable to external electromagnetic interference (e.g., patient monitors, surgical lasers, tomographs) must prove compliance regarding emissions and immunity. Satisfying these requirements is established through accredited laboratory trial protocols included directly in the registration dossier.

2. Metrological Pattern Approval (PAC Certificate):
Medical equipment providing specified diagnostic measurement functions (e.g., diagnostic ultrasound systems, digital clinical thermometers, non-invasive blood pressure monitors, radiation dosimeters) is legally categorized as measuring instrumentation. In Russia, Order No. 257n of the Ministry of Healthcare governs the specific list of medical measuring instruments that, beyond the Registration Certificate, require an independent Pattern Approval Certificate to legally verify measurement accuracy.

EAC certification of medical devices and pharmaceuticals

Labeling of Medical Devices: The EAC-MED Mark

EAC-MED conformity mark for medical devices

Medical devices authorized under the centralized EAEU regulatory framework must bear the designated EAC-MED mark prior to being placed on the market (Decision No. 26 of the EEC Council).

Marking Specifications:

  • The official mark consists of the graphic elements "EAC" and the addition "MED" enclosed in a defined square frame maintaining a height-to-width ratio of exactly 30 : 28 (minimum width 6 mm).
  • It must be affixed visibly, legibly, and permanently on each packaging unit and directly within the Instructions for Use (IFU).
  • Labels must display the registration certificate number and issue date, manufacturer name, batch or serial numbers, expiration date, and sterility data in Russian (and the state language of the destination country, where required).
  • Products registered purely through national Russian procedures do not bear the EAC-MED mark, but display the respective national Russian marking instead.

Authorized Representative for Medical Devices

Authorized representative for medical devices in the EAEU

A foreign manufacturer without an incorporated legal entity inside the EAEU customs territory cannot independently file medical device registration dossiers. Designating an Authorized Representative residing within an EAEU member state is an explicit statutory obligation.

The Authorized Representative acts as the official liaison toward the state health inspectorates (Roszdravnadzor, etc.), maintains the technical files, and bears co-responsibility within the framework of the pharmaco- and materiovigilance incident reporting systems.

Schmidt & Schmidt operates as an independent Authorized Representative. This ensures all regulatory ownership rights remain exclusively with you as the manufacturer, avoiding commercial dependency on commercial distributors or importers.

Sanctions Compliance for Medical Technology and Laboratory Systems

While humanitarian medical goods and finished pharmaceutical products are widely exempt from basic sanctions packages, sophisticated medical instruments, clinical imaging systems, laboratory chemicals, analytical reagents, and high-precision components face strict export control restrictions imposed by the EU (Council Regulation (EU) No 833/2014) and the United States. Many high-end diagnostic systems are categorized as dual-use goods or fall under advanced technology export bans.

Furthermore, commercial interactions with sanctioned military-affiliated hospitals, state medical institutes, or designated banks are prohibited under SDN lists. Exporters require rigorous end-use and end-user verification procedures.

Legal Security via Kazakhstan: Schmidt & Schmidt maintains corporate offices in Almaty and Astana. As a founding member state of the EAEU, Kazakhstan houses fully accredited testing institutes and competent health ministries. Pursuing registration through Kazakhstan as the Reference State ensures fully legitimate Union-wide market access while guaranteeing compliance with Western trade and banking regulations.

For more detailed background, consult our briefing: EAC Certification and Compliance within the Context of International Sanctions.

Sanctions screening for medical products

Duration, Costs, and Document Delivery

The registration of medical devices represents one of the most comprehensive regulatory procedures in the Eurasian region. Overall costs and processing lead times depend on the assigned risk class, the required depth of clinical studies, and on-site manufacturing audits:

  • Processing Timeframes: Typically 6 to 12 months for Class 1 and Class 2a devices, or 10 to 18 months for Class 2b and Class 3 equipment involving extensive clinical trials and on-site factory audits.
  • Period of Validity: The issued Registration Certificate is permanent (unlimited validity).
  • Letter of Exemption: Official confirmation of non-registration status is typically issued within 1 to 2 weeks.
Upon approval and formal entry into the state register, you will immediately receive electronic registry extracts. The official Registration Certificate printed on anti-counterfeiting security paper is securely delivered directly to your corporate address via international courier.

How Does the Medical Device Registration Work with Schmidt & Schmidt?

We guide medical technology manufacturers systematically through every phase of the Eurasian regulatory process up to market release:

01 Classification & Strategy

We review your medical device portfolio, establish risk classes, and determine the optimal authorization pathway (EAEU centralized route vs. national registration, reference state selection).

02 Dossier Compilation

Our engineers structure the Technical File per EAEU standards, compile risk management files, and translate instructions for use into compliant technical Russian.

03 Import Permit & Logistics

We obtain the statutory import permit from the healthcare inspectorates and coordinate compliant customs logistics for test sample shipments.

04 Testing & Audit Support

We oversee technical, toxicological, and clinical trials in accredited institutes and prepare your manufacturing plant for the official QMS inspection.

05 Regulatory Approval

We submit the complete registration dossier to the competent authorities, handle inquiries during the expertise phase, and manage mutual recognition in target states.

06 Approval & Mandate

You obtain the permanent Registration Certificate. Acting as your Authorized Representative, we maintain ongoing post-market surveillance and vigilances duties.

updated: